Genome & Company
Venture Capital
South Korean KOSDAQ-listed clinical-stage biotech making strategic equity investments in complementary microbiome and immuno-oncology companies.
Seoul, South Korea · 1+ investments
Growth
Biotech
immuno-oncology
microbiome
- Headquarters
- Seoul, South Korea
- Website
- genomeandcompany.com
- Total Investment
- 1
- Last Investment
- Aug 2020
- Geographic Focus
- South Korea, United States
Investment Thesis
Strategic investments in microbiome and cancer therapeutics companies that complement Genome & Company's own drug pipeline.
Genome & Company is a Venture Capital firm based in Seoul, South Korea. It has made 1 investment in Biotech and immuno-oncology.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.